Over the last decade Polpharma Biologics has created a biotechnology sector almost from scratch in Poland, consistently investing not only in laboratories and production lines, but also in know-how, driving growth of highly-qualified jobs, as well as developing cooperation between science and business. It was Polpharma Biologics that established a team with best-in-class specialists leading operations and sharing knowledge gained from the best biotechnology companies in the world.
Currently, there is no company on the Polish market with scale comparable to ours and with a similar business model. We are able to handle new drugs from the discovery stage to large scale production. There are currently eight molecules in our portfolio of biosimilar drugs.